Rankings
▼
Calendar
CAMP FY 2025 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$125M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+436.5% YoY
Gross Profit
$2M
53.1% margin
Operating Income
-$52M
-1488.3% margin
Net Income
-$80M
-2298.5% margin
EPS (Diluted)
$-2.65
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$30M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$118M
Total Liabilities
$70M
Stockholders' Equity
$48M
Cash & Equivalents
$110M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$652,000
+436.5%
Gross Profit
$2M
$652,000
+185.1%
Operating Income
-$52M
-$53M
+1.9%
Net Income
-$80M
-$52M
-55.2%
← Q4 2024
All Quarters
Q1 2025 →